Hikma: FTSE 100 giant’s boss replaced by former chief after share price woes pharma The boss of FTSE 100 giant Hikma Pharmaceuticals will be replaced by the firm’s former top chief after the group’s share price dropped by nearly a quarter this year. Riad Mishlawi has exited his role as chief executive at Hikma, with executive chairman Said Darwazah to step into the post with “immediate effect”. It ends [...]
No-zempic: Jolly Brits swap weight-loss jabs for stuffing this Christmas healthcare Brits are set to go all out this Christmas as nearly half plan to swap out their weight loss jabs for an extra helping of turkey and pudding. One in three don’t plan to return to their normal dose until after New Year in order to take full advantage of the festive season, according to [...]
GSK shares rally as chief Emma Walmsley to exit after eight years pharma The chief executive of pharmaceutical giant GSK has announced plans to step down from the company at the end of the year. Emma Walmsley, who took the helm of the drugmaker in 2017, will be replaced by chief commercial officer Luke Miels. Miels – the former Executive Vice President of Astrazeneca – also joined the [...]
Boots: Profit jumps after closing hundreds of stores June 5, 2025 Profit at Boots has surged as the high street pharmacy chain closed hundreds of stores during its latest financial year as its owners abandoned plans for an initial public offering (IPO). The Nottingham-headquartered business shuttered 334 locations in the year to the end of August 2024, new accounts filed with Companies House have revealed. Instead [...]
GSK and Astrazeneca shares slump as Trump vows drug price cut May 12, 2025 GSK and Astrazeneca shares fall as Trump announces drug price cuts in a new executive order.
Boots warns of higher Budget costs amid sales surge January 10, 2025 High street pharmacy giant Boots has warned it faces “heightened cost pressures” in 2025 following the Autumn Budget as it revealed strong sales towards the end of last year. The new boss of the Nottingham-headquartered company, Anthony Hemmerdinger, added that while Boots has come under increased pressure, “the business is focused on navigating these and [...]
The Notebook: Why pharmacies could be key to NHS reform November 6, 2024 Want to reform the NHS? How about using the assets we've already got, writes Charac CEO Santosh Sahu in today's Notebook.
New Boots UK boss named after Seb James’ departure and aborted IPO September 12, 2024 Anthony Hemmerdinger has been appointed managing director of Boots UK and Ireland only months after the high street pharmacy chain’s US parent company once again shelved plans to sell or list the business. Current managing director Seb James, who has run the company since 2018, will pursue a new role in the healthcare sector. Hemmerdinger [...]